GRM5 and Dyskinesia: Furthermore, the mGluR5 antagonist MTEP was shown to prevent dyskinesias induced by an acute challenge of L-Dopa following weeks of L-Dopa priming in 6-OHDA-lesioned rats (Dekundy et al., 2006; Rylander et al., 2009).